Mesoblast
Obat-obatan seluler dan produk terapi sel alogenik.
Mesoblast memproduksi obat-obatan seluler dan produk terapi sel alogenik dari operasinya di Melbourne. Perusahaan ini memasok sistem perawatan kesehatan, laboratorium, mitra OEM, atau pelanggan ekspor teregulasi di seluruh pasar utama terdaftarnya.
- Type
- Manufacturer
- Location
- Melbourne, Australia
- Founded
- 2004
- Website
- mesoblast.com
- Categories
- Perlengkapan Medis & Kesehatan
- Markets
- Australia, Amerika Serikat, Jerman, Jepang
Verified facts
- lei-lapsed (amber), checked 2026-08-07 GLEIF global LEI register (golden copy)
Claimed certifications
- Good Manufacturing Practice
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)